Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Our team is comprised of industry leaders with decades of experience in early stage biotechnology startups, translational drug development, and practice-changing Phase III clinical trials.
oragen is preparing to initiate a Phase I clinical trial with its lead compound in HPV-associated malignancies and i...
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Our team is comprised of industry leaders with decades of experience in early stage biotechnology startups, translational drug development, and practice-changing Phase III clinical trials.
oragen is preparing to initiate a Phase I clinical trial with its lead compound in HPV-associated malignancies and is seeking investor funding for research and development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.